Stefano, L. A. D., Kim, H., Erickson, C. A., Pedapati, E. V., Dominick, K. C., Shaffer, R., Wink, L. K., Schmitt, L. M., Miyakoshi, M. (2026). Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome. Scientific Reports. https://doi.org/10.1038/s41598-026-44380-0